Did you mean 136 4s 3?
Displaying drugs 8351 - 8375 of 11953 in total
4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME
Experimental
Matched Name: … 4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME …
Matched Iupac: … 4-{4-[(E)-(hydroxyimino)methyl]naphthalen-1-yl}phenol …
Matched Iupac: … 4-{4-[(E)-(hydroxyimino)methyl]naphthalen-1-yl}phenol …
2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL
Experimental
Matched Name: … 2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL …
Matched Iupac: … 2-[(1R)-1-(4-chlorophenyl)ethyl]-4,6-dinitrophenol …
Matched Iupac: … 2-[(1R)-1-(4-chlorophenyl)ethyl]-4,6-dinitrophenol …
1,3-Propanediol
Experimental
Trencam-3,2-Hopo
Experimental
AEG35156
A second-generation synthetic antisense oligonucleotide with potential antineoplastic activity. AEG35156 selectively blocks the cellular expression of X-linked inhibitor of apoptosis protein (XIAP), a pivotal inhibitor of apoptosis that is overexpressed in many tumors. This agent reduces total levels of XIAP in tumor cells, working synergistically with cytotoxic drugs to overcome...
Investigational
GED-0507-34-Levo
GED-0507-34-Levo is under investigation in clinical trial NCT02808390 (Efficacy and Safety Study of Ged-0507-34-levo for Treatment of UC).
Investigational
Matched Iupac: … (2S)-3-(4-aminophenyl)-2-methoxypropanoic acid …
Proglumetacin
Experimental
Matched Iupac: … 3-{4-[2-({2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetyl}oxy)ethyl]piperazin-1-yl}propyl ... 4-(dipropylcarbamoyl)-4-(phenylformamido)butanoate …
Metildigoxin
Experimental
Matched Iupac: … 4-[(1S,2S,5S,7R,10R,11S,14R,15S,16R)-11,16-dihydroxy-5-{[(2R,4S,5S,6R)-4-hydroxy-5-{[(2S,4S,5S,6R)-4- ... hydroxy-5-{[(2S,4S,5S,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan …
4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol
Experimental
Matched Name: … 4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol …
Matched Iupac: … 4-{2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl}phenol …
Matched Iupac: … 4-{2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl}phenol …
4-Hydroxyphenylpyruvic acid
Experimental
Matched Synonyms: … (4-hydroxyphenyl)pyruvic acid …
Matched Name: … 4-Hydroxyphenylpyruvic acid …
Matched Iupac: … 3-(4-hydroxyphenyl)-2-oxopropanoic acid …
Matched Name: … 4-Hydroxyphenylpyruvic acid …
Matched Iupac: … 3-(4-hydroxyphenyl)-2-oxopropanoic acid …
Medicago sativa top
Experimental
Phloretin
Phloretin is a natural dihydrochalcone found in apples and many other fruits.
Experimental
Matched Iupac: … 3-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)propan-1-one …
Sodium dichloroacetate
Investigational
XL999
XL999 has the potential to provide benefit to patients with lung cancer and acute myelogenous leukemia. XL999 is a new chemical entity that inhibits a spectrum of receptor tyrosine kinases (RTKs) with growth promoting and angiogenic properties, including FGFR 1/3, PDGFRα/β, VEGFR2/KDR, KIT, and FLT3. XL999 also inhibits FLT4 and...
Investigational
Matched Description: … receptor tyrosine kinases (RTKs) with growth promoting and angiogenic properties, including FGFR 1/3, …
Inactivated SARS-Cov-2 Vaccine
Developed by Sinopharm's Wuhan Institute of Biological Products co., this vaccine consists of the WIV04 strain of SARS-CoV-2. This strain was isolated from a patient in Wuhan, cultivated in a Vero cell line, and then subsequently inactivated using B-propiolactone. Double-blind, randomized, placebo-controlled phase 1 (96 participants) and phase 2 (224...
Investigational
Matched Description: … [A220158] Currently, the vaccine is being tested in Phase 3 clinical trial in Abu Dhabi (ChiCTR2000034780 …
Rocacetrapib
Rocacetrapib is under investigation in clinical trial NCT02156544 (Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519).
Investigational
Matched Iupac: … (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-({2-[4-fluoro-2-methoxy-5-(propan-2-yl)phenyl]-5,5-dimethylcyclohex ... -1-en-1-yl}methyl)-4-methyl-1,3-oxazolidin-2-one …
4-phospho-D-erythronic acid
Experimental
Matched Synonyms: … 4-Phosphoerythronate ... 4-Phospho-D-Erythronate …
Matched Name: … 4-phospho-D-erythronic acid …
Matched Iupac: … (2R,3R)-2,3-dihydroxy-4-(phosphonooxy)butanoic acid …
Matched Name: … 4-phospho-D-erythronic acid …
Matched Iupac: … (2R,3R)-2,3-dihydroxy-4-(phosphonooxy)butanoic acid …
Carlecortemcel-L
Investigational
1-hydroperoxy-L-tryptophan
Experimental
Matched Iupac: … (2S)-2-amino-3-(1-hydroperoxy-1H-indol-3-yl)propanoic acid …
5-aminonaphthalene-2-sulfonic acid
Experimental
9-(4-Hydroxyphenyl)-2,7-Phenanthroline
Experimental
Matched Name: … 9-(4-Hydroxyphenyl)-2,7-Phenanthroline …
Matched Iupac: … 4-(2,7-phenanthrolin-9-yl)phenol …
Matched Iupac: … 4-(2,7-phenanthrolin-9-yl)phenol …
Ara-Alpha(1,3)-Xyl
Experimental
Matched Iupac: … (2R,3R,4S,5R)-4-{[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}oxane-2,3,5-triol …
AAV1-FS344
AAV1-FS344 is an investigational gene therapy developed by Milo Biotechnology to deliver follistatin, a potent myostatin inhibitor. It is being investigated for the treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and inclusion body myositis.[L46742, L46747, L46752]
Investigational
Displaying drugs 8351 - 8375 of 11953 in total